Italy
BMG Pharma, an Italian B2B biotech company founded in 2006, specializes in the development and out-licensing of innovative patented products in the biotechnology industry. The company focuses on healthcare solutions in dermatology, dermal aesthetics, oral care, osteoarthritis, and women's health, utilizing its patented Hyaluromimethic® Technology to develop a range of products. BMG Pharma has a strong portfolio of intellectual property and a track record of developing patented products and functional ingredients.
The company's recent milestone includes securing a €2.00M Venture Round investment on April 29, 2021, with the investment coming from Friulia Finanziaria FVG. This funding is expected to further propel BMG Pharma's product development and partnership initiatives, allowing the company to expand its global network of partners by out-licensing its innovative healthcare products.
BMG Pharma's expertise in healthcare product development and partnering, coupled with its commitment to scientific innovation, positions it as a promising player in the biotech industry, offering a blend of established marketed products and a robust pipeline of new developments.
Athena Pharmaceutiques S.A.S.
